Tarek I. Hassanein

Gastroenterology

27700 Medical Center Road
Mission Viejo, CA 92691

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis.

A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis.

Journal: Hepatology (Baltimore, Md.)

Published: December 04, 2025

Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis.

Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis.

Journal: Scientific reports

Published: August 22, 2025

Methods and Validation of Velacur Determined Fat Fraction in patients with MASLD.

Methods and Validation of Velacur Determined Fat Fraction in patients with MASLD.

Journal: WFUMB ultrasound open

Published: May 26, 2025

Letter: Enhancing the Diagnostic Performance of the Oral Cholate Challenge Test: Implications for Avoidance of Potentially Unnecessary Endoscopy.

Letter: Enhancing the Diagnostic Performance of the Oral Cholate Challenge Test: Implications for Avoidance of Potentially Unnecessary Endoscopy.

Journal: Alimentary pharmacology & therapeutics

Published: March 20, 2025

Bacterial Infections in Patients With Severe Alcohol-Associated Hepatitis: Drivers of Organ Failure and Mortality.

Bacterial Infections in Patients With Severe Alcohol-Associated Hepatitis: Drivers of Organ Failure and Mortality.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 04, 2025

Editorial: Reading the cholate-A new gateway to portal hypertension and oesophageal varices: Authors' reply.

Editorial: Reading the cholate-A new gateway to portal hypertension and oesophageal varices: Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: June 26, 2024

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.

Journal: Journal of hepatology

Published: April 22, 2024

Deep Learning Based Shear Wave Detection and Segmentation Tool for Use in Point-of-Care for Chronic Liver Disease Assessments.

Deep Learning Based Shear Wave Detection and Segmentation Tool for Use in Point-of-Care for Chronic Liver Disease Assessments.

Journal: Ultrasound in medicine & biology

Published: April 04, 2024

Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices.

Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices.

Journal: Alimentary pharmacology & therapeutics

Published: February 14, 2024

Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.

Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.

Journal: Hepatology communications

Published: September 28, 2023

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.

Journal: JHEP reports : innovation in hepatology

Published: August 17, 2023

Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.

Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.

Journal: The American journal of gastroenterology

Published: November 17, 2022

Showing 1-12 of 83

Last Updated: 09/26/2026